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Abstract  
This paper provides a first glimpse of the use of business intelligence (BI) into healthcare and wellbeing. 
There are new and exciting possibilities to use BI business intelligence in this area.  With the help of big 
data technologies, there is interest from public and private organisations, academic researchers, health 
professionals and technology vendors to implement as well as evaluate the impact of BI.  A potentially 
important issue is that of the openness of the data for BI which could have repercussions for different 
actors.  .  In relation to the ‘openness’ of the data being managed, we identify a number of challenges.  
Discussion of these issues should inform future research and practice in BI in this area and elsewhere. 
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The emergence of Business Intelligence (BI) and its use in human healthcare and 
wellbeing contexts creates opportunities to extract and use relevant knowledge obtained 
from analysing large volumes of data. Generally speaking, BI is a set of processes 
supported by technologies that enable people to discover patterns that are ‘hidden’ in the 
data to the human eye in order to inform decisions.  Technologies to process and analyse 
data include transactional databases, data warehouses, online analytical processing 
(OLAP) and data mining tools and techniques (Laudon and Laudon, 2013; Chen et al, 
2012). With BI, better, specialised and cost effective services and treatments can also 
yield benefits for payers and the public in general.  
 
With new technologies and practices of big data in these contexts, there is interest from 
different stakeholders (public and private organisations, health professionals, technology 
vendors and patients) to better understand the role that BI could play and more 
specifically the issues related to the openness of data.   The purpose of this paper is to 
provide a brief overview as well as an initial evaluation of what would happen if data 
generated from BI would be made open to different stakeholders and more specifically to 
prospective and current healthcare and well being users.  This would require addressing a 
number of issues in both the design as well as implementation of BI.  In the next section 
an overview of BI in healthcare is presented. 
 
2.0 What we know so far:  Business Intelligence in Healthcare and 
Wellbeing 
 
Business intelligence or BI in healthcare is relatively a young area of research and 
practice.  There are different technologies that have been applied to healthcare problems 
ranging from telemedicine to detailed analysis of human tissue for detection of illnesses 
(i.e. cancer) (Laudon and Laudon, 2013; Chen et al, 2012).  Wellbeing is a 
complementary area to healthcare regarding health prevention and is taking shape in the 
form of early detection of diseases as well as support for quality of life improvement 
personal programmes (Stewart and Ware, 1992)    
 
In trying to understand how new technologies of big data for BI as well as government 
policies to ‘open’ healthcare data, a future trend is that of conceptualising BI as part of an 
ecosystem of data in which different actors, their values and interests intersect and 
mutually co-evolve and use latest technologies to both generate as well as access data 
(Chen et al, 2012; Harrison et al. 2012).  The following diagram follows Mettler and 
Virmalund (2009)’s framework and provides an overview of BI in the healthcare context.  
This framework can be discussed and enriched with actors as new technologies and 
policies affecting both healthcare/wellbeing contexts are formulated and implemented by 
governments.   
 
  
Figure 1. A framework for Business Intelligence in Healthcare (and Wellbeing) (from Mettler 
and Virmalund, 2009). 
In the diagram, it can be seen that the main components include processes, actors, 
information technologies and data.  Of particular importance is the distinction between 
information and data.  Data are sets of raw measurements and facts which are collected 
from different sectors and from different actors involved (Stewart and Ware, 1992; Scott, 
2012). In turn information is the representation of those facts and measurements through 
analysed reports or visualised graphs. Data are normally machine readable facts and the 
result of processing them will generate the information that is used by human actors in 
the system.  The main sources of data include: 
 Clinical data sources, which are required to provide and deliver 
healthcare/wellbeing services and products to patients. These are all medical data 
collected from patient records, laboratory results, treatment process and follow 
ups. With current policies in countries like the UK, billions of personal health 
records are being created, made anonymous and sold to third parties (i.e. market 
research companies) (Sunday Times, 2014).   
 Administrative data, which are needed to run the healthcare business and 
organisation. These data are business data from organisational actors’ personnel 
data, financial data and back office requirements. 
 External data that includes external providers’ clinical or administrative data such 
as statistical data, medical reports or insurance forms. 
 
As the data comes from different sources and is used in various ways, in BI for healthcare 
what is also relevant to note is the diversity of actors involved. Unlike other industries, 
there are clinical and administrative actors.  Each of these needs different access and 
reporting mechanisms. Furthermore BI solutions could –in principle offer data to a 
variety of users (actors) with diverse needs (e.g. patients, insurance companies, 
governmental authorities, doctors).  These can be seen as customers whose behaviour and 
expectations differ from one to the other.  Considering this diversity, BI solutions should 
also include some soft metrics to include patient’s feelings and choices, as well as hard 
metrics that are required to monitor and evaluate the business performance of 
organisational actors (Avison and Young, 2007)  
 
3.0 Meaningful use 
 
Successful BI implementation in healthcare can be expensive and difficult.  Achieving 
desired benefits is a slow process until benefits become apparent and perceived by 
different actors. A managerial and linear perspective on BI would suggest that its 
implementation should be gradual, in other words ‘lineally oriented’, and in each stage 
there should be clear objectives to achieve.  In countries like the US, there are different 
legislations to clarify different stages and objectives for each one (Blumenthal and 
Tavenner, 2010).  These are: 
 
 Creating and gathering information including the entry of basic data such as 
patients’ vital signs, demographics, up-to-date list of problems and current 
diagnoses, current and active medications, allergies, tobacco status and weight 
screening (Blumenthal and Tavenner, 2010).  
 Use of BI applications to ‘discover patterns’ and hence reveal the true potential of 
these systems to advance quality, efficiency and safety of care.  With patterns, 
providers could have better access to patients’ information for a better decision 
making as well as avoiding preventable errors (Blumenthal and Tavenner, 2010). 
For instance, there are BI examples that have supported large case-control of 
pancreatic cancer risks. Using BI, researchers have analylsed electronic records 
for symptomatic patients in primary care to identify and quantify the features of 
pancreatice cancer. (Stapley S., et al., 2012). Another example in this area is the 
discovery of patterns of cancer risk in patients with different hip replacements 
bearing surface types. The data that was used was the US General Practice 
Research Database which is part of the Clinical Practice Research Datalink 
(CPRD) and which collects computerised medical records from general 
practitioners (Lalmohamed A., et al., 2013).   
 Patient empowerment.  This is achieved by enabling patients to access their 
complete health records. BI systems also improve the personal healthcare that 
patients receive by performing different services such as: reminders for check-
ups, patient-specific health education, prescription checks, integrated clinical 
laboratory results as well as supporting patients’ transitions between care settings 
or personnel (Blumenthal and Tavenner, 2010). 
 
All these stages involve the generation of quality reports. These reports could identify 
and assess health providers’ performance and decision making, control medicine 
prescriptions as well as patients’ satisfaction. These reports may eventually become 
public (Blumenthal and Tavenner, 2010). 
4.0 Opening the data from BI 
Current government policies in countries like the US and the UK encourage the opening 
up of healthcare data (Harrison et al, 2012).  The idea is to generate an ecosystem in 
which data circulates through different actors and is recycled to fulfil a number of goals.  
There can be new technological innovations in the form of for instance software 
applications that use the data for the benefit of patients.  In addition, patients can exert 
better accountability over their healthcare providers and use data to provide evidence and 
argue their case against government (Harrison et al, 2012; Gurstein, 2011).  Finally, 
governments can assess the impact of their health policies in several areas as well as the 
quality of services provided by third parties.   
 
The opening of data follows a general trend to open government to public accountability 
and facilitate citizens’ engagement with new technologies like social media (Lee and 
Kwak, 2012).  Within this trend, and similar to BI, the idea is to follow a linear process 
of development.  Lee and Kwak (2012) show this process when they set out the following 
stages for open government:  initial conditions (availability of data, Level 1), data 
transparency (making data accessible, Level 2), open participation (encouraging citizens’ 
access, Level 3), open collaboration (data partnerships Level 4), and ubiquitous 
engagement (use of social media, Level 5).   
 
BI ‘3.0’ (including big data technologies as stated by Chen et al 2012) can follow a 
similar pattern and transform healthcare and wellbeing from being disease control based 
to patient centred.  With the help of new applications that make use of sensor, mobile and 
social media technologies, more sophisticated health monitoring and analysis, health text 
analytics, health ontology definitions, patient network analysis as well as economic 
analysis can be performed (Chen et al, 2012). However, when it comes to ‘opening up’ 
the BI data of such analyses to users (patients), there are a number of issues which 
policies and initiatives will need to consider.  The following issues are proposed to be 
considered in BI in health care/wellbeing initiatives as ‘open’ data: 
 
 Data neutrality and contextualisation.  According to Johnson (2013), “it is 
exceptionally easy for data scientists and users to accept current data practices and 
outcomes as natural or inevitable, and to make data use the only moral question of 
interest” (pp.2).    Even the opening of people’s data is not going to benefit them 
unless the assumptions and worldviews that led to the construction of such data 
are critically reviewed and discussed.  This is the case for instance of 
marginalised communities or minorities whose data does not tell much about them 
(there is not much data that they were able to fill) (Gurstein, 2011; Johnson, 2013) 
and therefore any future initiative is not going to be of much help to them.   
 
 Future use of data.  This is one of the biggest concerns posed by the public.  
Although people are often promised that their own personal data is to be made 
anonymous and is to be managed by ‘bona fide’ experts (business intelligence 
analysts, health professionals and scientists among others), experience in 
countries like the US with the human genome data shows that once data is 
collected, aggregated and analysed, it can be sold to third parties which can then 
use it to produce commercial solutions (i.e. drugs).   The case of the NHS in the 
UK (Sunday Times, 2014) shows that governments have already established 
bilateral partnerships which go contrary to the philosophy of open data, in which 
governments provide some guiding intentions for the use of data but then 
facilitate collaboration, co-operation and the achievement of public value through 
the work of different actors in open data initiatives (Harrison et al, 2012).  
Patients who want to opt out from this initiative have to fill forms and check on 
the process.  An espoused rationale for building big data infrastructures based on 
citizens’ trust can be eroded if data is used for commercial purposes (Dickenson, 
2014; Sunday Times, 2014).  This could affect negatively the future engagement 
of citizens in healthcare/wellbeing policies and initiatives. 
 
 Ownership of data.  The future management of large volumes of data requires 
important investments in resources as well as decisions on who is to own its 
preservation (Lynch, 2008).  In countries like the UK, Universities seem to be 
taking the lead in collecting and storing online data (Pritchard and Whiting, 
2012).  In other parts of the world, well-being BI initiatives are emerging.  A 
long-term strategy to store and making data available to different actors should be 
defined alongside the design of BI initiatives.   
 
 Accuracy of data.  The experience of using human genome data shows that 
analysis of big data can produce different results.  Analysis techniques are still 
unproven and increasingly being refined.  If analysis data is available for direct 
public consumption there could be different answers provided to them with the 
risk of contradictory well-being decisions being made (Dickenson, 2014).  In the 
context of BI for healthcare and wellbeing, the distinction between data and 
information is a key one if people are going to be provided with meaningful BI 
information.  
 
 Transparency and accountability.  The collection, gathering and analysis of data 
can become a public source of transparency and accountability of healthcare and 
wellbeing professionals.  Information provided by BI initiatives can put into 
question the knowledge and expertise that is exhibited by these professionals, in 
particular if the aim of their organisations show transparency to the public via 
electronic data (Gabe et al. 2012). However, in achieving transparency and 
accountability it is important to promote data literacy.  Gurstein (2011) makes a 
case for empowering the citizens rather than simply enabling them to access data.  
In particular when data is being summarised, it loses its context, in other words it 
loses its meaning and therefore meaning for citizens needs to be created. Data 
literacy needs to be encouraged, and in doing so the role of intermediaries is 
essential to both help citizens analyse the data as well as use it in a relevant 
context of application.   
 
 Social media use for data collection.  According to Lee and Kwak (2012), social 
media technologies can be a supporting platform to facilitate citizens’ 
engagement.  However, other actors from the BI ‘ecosystem’ (i.e. government) 
could be gathering citizens’ data without citizens being fully informed or being 
aware of it (Oboler et al, 2012).  This is worrying, given that often citizens rely on 
their governments to protect them from invasion to their privacy by commercial 
actors. Open discussions about how data is to be used should inform future 
development of BI initiatives. 
 
These and other issues are interconnected and require a holistic system of enquiry to 
address them, one which is critically constructive of the ecosystem one.  Given their 
social, ethical and technical nature, they also signal the importance of adopting a less 
functionally oriented and linear approach in favour of a more ethical and human centred 
perspective to BI in the healthcare and wellbeing contexts.  If this is the case, it becomes 
important to facilitate debate or dialogue about what / who should constitute relevant and 
legitimate aims, actors and potential effects of BI initiatives, in particular in relation to 
their potentially ‘open’ nature; the meaning of ‘open for what’ and ‘open to whom’ 
should be discussed.  A possibility is to adopt a systems thinking approach to enable 
dialogue, participative and consultative design and evaluation of BI initiatives.  Intending 
to take this further, future research stages will include studying further applications of BI 
in these contexts as well as exploring systems thinking methods and approaches to 
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